Labcorp Holdings (LH) Total Non-Current Liabilities (2009 - 2026)
Labcorp Holdings' (LH) quarterly Total Non-Current Liabilities came in at $9.6 billion in Q1 2026, up 9.85% year-on-year from $8.8 billion in Q1 2025, and up 5.95% quarter-over-quarter from $9.1 billion in Q4 2025.
Labcorp Holdings (LH) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
Labcorp Holdings has disclosed Total Non-Current Liabilities across 18 years of filings, most recently posting $9.6 billion for Q1 2026.
- Total Non-Current Liabilities for Q1 2026 came in at $9.6 billion, up 9.85% year-over-year; the trailing twelve-month figure through Mar 2026 was $9.6 billion (up 9.85% YoY), and the FY2025 annual result was $9.1 billion, down 7.01% from the prior year.
- Total Non-Current Liabilities came in at $9.6 billion for Q1 2026 at Labcorp Holdings, up from $9.1 billion in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $9.9 billion in Q3 2024 to a low of $8.1 billion in Q1 2024.
- The 5-year median for Total Non-Current Liabilities is $9.1 billion (2025), against an average of $9.1 billion.
- Peak annual rise in Total Non-Current Liabilities reached 16.26% in 2024, while the deepest fall reached 14.19% in 2024.
- Labcorp Holdings' Total Non-Current Liabilities stood at $9.6 billion in 2022, then dropped by 12.59% to $8.4 billion in 2023, then climbed by 16.26% to $9.8 billion in 2024, then slipped by 7.01% to $9.1 billion in 2025, then grew by 5.95% to $9.6 billion in 2026.
- The last three Total Non-Current Liabilities figures came in at $9.6 billion (Q1 2026), $9.1 billion (Q4 2025), and $8.9 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 6.97 Bn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 56.93 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 25.03 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 529.54 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 5.45 Bn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 737.18 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 22.71 Bn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 3.53 Bn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 3.42 Bn |
| 10 | Labcorp Holdings | 22.31 Bn | 21.34 Bn | 1.01 Bn | 9.65 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.65 Bn |
| Dec 31, 2025 | 9.11 Bn |
| Sep 30, 2025 | 8.91 Bn |
| Jun 30, 2025 | 8.93 Bn |
| Mar 31, 2025 | 8.78 Bn |
| Dec 31, 2024 | 9.80 Bn |
| Sep 30, 2024 | 9.90 Bn |
| Jun 30, 2024 | 8.21 Bn |
| Mar 31, 2024 | 8.09 Bn |
| Dec 31, 2023 | 8.43 Bn |
| Sep 30, 2023 | 8.57 Bn |
| Jun 30, 2023 | 8.50 Bn |
| Mar 31, 2023 | 9.43 Bn |
| Dec 31, 2022 | 9.64 Bn |
| Sep 30, 2022 | 9.28 Bn |
| Jun 30, 2022 | 9.50 Bn |
| Mar 31, 2022 | 9.50 Bn |
| Dec 31, 2021 | 9.69 Bn |
| Sep 30, 2021 | 9.83 Bn |
| Jun 30, 2021 | 9.65 Bn |